What are the Advantages of Web Based Health Economics Models for Devices Market Access ?

Despite the prevailing trend of “consumerization of information technologies”, many mathematical models in various industries (life science, financial, R&D etc.) remains Excel-based. Yet a few years ago, IT was mostly associated with technical specialists – people with sufficient software/hardware knowledge and skills, but recently IT has become more accessible and easy to use for wider audience. Thus, removing main barriers for transformation of mathematical models (health economics, financial, etc) into a more interactive and customer-oriented form with much wider scope for development and customization.

Needless to say, custom development, as against traditional Excel, also enables new presentation layer options, which usually take the form of nice looking and interactive dashboards, while model inputs are done in the form of interactive sliders, drop boxes, radio buttons, checkboxes etc.

So let’s take a closer look at the reasons for Excel models to be transformed into more interactive and custom form:

Advantages offered by interactive models are primarily related to model usage and lifecycle management. These models can be viewed on any hardware device or browser, thus overcoming the limitations of Excel models. The use of latest web technologies such as JavaScript, HTML5 and CSS3 improve user experience in model adaptation and presentation to end audience. They also highly increase the perception of the information by audience.

Usage analytics, improved usability, web sharing and automatic updates are the functional advantages that cannot be achieved with conventional Excel models due to technical limitations.

Oleksandr Topachevskyi

Oleksandr Topachevskyi


Oleksandr is a health economist with a strong background in economic evaluations of healthcare programmed and health economics modelling, epidemiology, statistics, patient reported outcomes data collection and software solutions development. From 2009 to 2014 he worked at in GlaxoSmithKline Vaccines HQ at a position of a global health economics manager.

More about author

Leave a Reply

Your email address will not be published.